BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11850532)

  • 21. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
    Ruiz ML; Villanueva SS; Luquita MG; Ikushiro S; Mottino AD; Catania VA
    Drug Metab Dispos; 2007 Nov; 35(11):2060-6. PubMed ID: 17686906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice.
    Tanaka Y; Kobayashi Y; Gabazza EC; Higuchi K; Kamisako T; Kuroda M; Takeuchi K; Iwasa M; Kaito M; Adachi Y
    Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G656-62. PubMed ID: 11897625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.
    Muchova L; Vanova K; Suk J; Micuda S; Dolezelova E; Fuksa L; Cerny D; Farghali H; Zelenkova M; Lenicek M; Wong RJ; Vreman HJ; Vitek L
    J Cell Mol Med; 2015 May; 19(5):924-33. PubMed ID: 25683492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats.
    Cherrington NJ; Hartley DP; Li N; Johnson DR; Klaassen CD
    J Pharmacol Exp Ther; 2002 Jan; 300(1):97-104. PubMed ID: 11752103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids.
    McCarthy TC; Li X; Sinal CJ
    J Biol Chem; 2005 Jun; 280(24):23232-42. PubMed ID: 15824121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3).
    Hirohashi T; Suzuki H; Takikawa H; Sugiyama Y
    J Biol Chem; 2000 Jan; 275(4):2905-10. PubMed ID: 10644759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobarbital treatment or phenobarbital pretreatment.
    Xiong H; Suzuki H; Sugiyama Y; Meier PJ; Pollack GM; Brouwer KL
    Drug Metab Dispos; 2002 Sep; 30(9):962-9. PubMed ID: 12167560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bile acids on the expression of MRP3 and MRP4: An In vitro study in HepG2 cell line.
    Pérez-Pineda SI; Baylón-Pacheco L; Espíritu-Gordillo P; Tsutsumi V; Rosales-Encina JL
    Ann Hepatol; 2021; 24():100325. PubMed ID: 33582321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
    Xiao L; Yi T; Chen M; Lam CW; Zhou H
    Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter.
    Inokuchi A; Hinoshita E; Iwamoto Y; Kohno K; Kuwano M; Uchiumi T
    J Biol Chem; 2001 Dec; 276(50):46822-9. PubMed ID: 11590139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manifestation of multidrug resistance protein 3 (MRP3) in liver and kidney cells in cholestasis: effects of hyperprolactinemia.
    Aleksandrova MI; Kushnareva NS; Smirnova OV
    Bull Exp Biol Med; 2013 Feb; 154(4):508-11. PubMed ID: 23486593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.
    Noma B; Sasaki T; Fujimoto Y; Serikawa M; Kobayashi K; Inoue M; Itsuki H; Kamigaki M; Minami T; Chayama K
    Int J Oncol; 2008 Dec; 33(6):1187-94. PubMed ID: 19020751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism.
    Chen P; Li J; Fan X; Zeng H; Deng R; Li D; Huang M; Bi H
    Eur J Pharmacol; 2015 Oct; 765():131-9. PubMed ID: 26297978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.
    Scheffer GL; Kool M; Heijn M; de Haas M; Pijnenborg AC; Wijnholds J; van Helvoort A; de Jong MC; Hooijberg JH; Mol CA; van der Linden M; de Vree JM; van der Valk P; Elferink RP; Borst P; Scheper RJ
    Cancer Res; 2000 Sep; 60(18):5269-77. PubMed ID: 11016657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney.
    Li CY; Basit A; Gupta A; Gáborik Z; Kis E; Prasad B
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105350. PubMed ID: 30959153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3.
    Chu XY; Huskey SE; Braun MP; Sarkadi B; Evans DC; Evers R
    J Pharmacol Exp Ther; 2004 Apr; 309(1):156-64. PubMed ID: 14722317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter.
    Zelcer N; Saeki T; Bot I; Kuil A; Borst P
    Biochem J; 2003 Jan; 369(Pt 1):23-30. PubMed ID: 12220224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene.
    Stöckel B; König J; Nies AT; Cui Y; Brom M; Keppler D
    Eur J Biochem; 2000 Mar; 267(5):1347-58. PubMed ID: 10691972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis.
    Soroka CJ; Mennone A; Hagey LR; Ballatori N; Boyer JL
    Hepatology; 2010 Jan; 51(1):181-90. PubMed ID: 19902485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions.
    Bodo A; Bakos E; Szeri F; Varadi A; Sarkadi B
    J Biol Chem; 2003 Jun; 278(26):23529-37. PubMed ID: 12704183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.